Keyphrases
Stereotactic Body Radiation Therapy
90%
Overall Survival
60%
Local Control
53%
Non-small Cell Lung Cancer (NSCLC)
32%
Institutional Experience
30%
RelB
30%
Astrocytes
27%
Survival Outcomes
25%
Sphingosine-1-phosphate
24%
Biologically Effective Dose
22%
Sphingosine Kinase 1 (SphK1)
21%
Large Language Models
20%
Glioblastoma multiforme
20%
Ovarian Cancer
20%
Interleukin-1β
19%
Spine
19%
Prostate
18%
Gene Expression
17%
Local Failure
17%
Lymph Node
17%
Radiation Oncologist
17%
Artificial Intelligence
17%
Kaplan-Meier Method
17%
Local Recurrence-free Survival
15%
Adenocarcinoma
13%
Breast Cancer
13%
Univariate Analysis
12%
Metastatic Breast Cancer
12%
Transcription Factor
12%
Yin-Yang
12%
Molecular Switches
11%
Cell Proliferation
11%
Recurrent Non-small Cell Lung Cancer
11%
Median Overall Survival
11%
Pulmonary Lesions
11%
Inter-fraction
11%
Inflammation
11%
Sterile Inflammation
10%
Metastasis
10%
Inclusion Criteria
10%
Small Dataset
10%
Dentate Gyrus of the Hippocampus
10%
Oligodendrocyte Maturation
10%
Stromal Reprogramming
10%
Whole Pelvic Radiotherapy
10%
Whole Pelvic Radiation Therapy
10%
Myf5
10%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
10%
Spinal Metastasis
10%
ABCC1
10%
Medicine and Dentistry
Stereotactic Body Radiation Therapy
100%
Overall Survival
71%
Non Small Cell Lung Cancer
44%
Radiation Therapy
35%
Progression Free Survival
29%
Metastatic Carcinoma
29%
Neoplasm
27%
Kaplan Meier Method
25%
Lymph Node
22%
Diseases
21%
Low Drug Dose
21%
Prostate Cancer
20%
Lung Lesion
20%
Breast Cancer
18%
Malignant Neoplasm
14%
Univariate Analysis
13%
Bladder
13%
Lung
12%
Pelvis
12%
Proportional Hazards Model
12%
Radiation Oncologist
12%
Adenocarcinoma
11%
Primary Tumor
10%
Sphingosine Kinase 1
10%
Sleep Disorder
10%
Pelvic Radiotherapy
10%
Spinal Cord Metastasis
10%
Tamoxifen
10%
Immunotherapy
10%
Squamous Cell Carcinoma
10%
Alanine Aminotransferase
10%
Transitional Cell Carcinoma
10%
Chemoradiotherapy
10%
Metastatic Breast Cancer
10%
Prognosis
10%
RNA Sequencing
10%
Adaptive Radiotherapy
10%
Estrogen Receptor
10%
Cervical Cancer
10%
Liver Metastasis
10%
Ovarian Cancer
10%
Prognostic Factor
10%
Spine Metastasis
10%
Recursive Partitioning
10%
Stereotactic Radiosurgery
10%
Recurrent Disease
8%
Predictive Factor
8%
Hazard Ratio
7%
Gene Expression
6%
Mesenchymal-Epithelial Transition
6%
